Corporate News 10-Sep-18
Ajanta Pharma update on scheme of amalgamation and arrangement
Ajanta Pharma announced that the Hon'ble National Company Law Tribunal, Mumbai Bench ('NCLT') did not deem it fit to approve and sanction the proposed Scheme of Amalgamation and Arrangement between Gabs Investments and Ajanta Pharma and their respective shareholders.
Previous News
Ajanta Pharma fixes record date for 2nd interim dividend
( Market Beat - Reports 31-Jan-24 17:37 )
Ajanta Pharma fixes record date for buyback of shares
( Market Beat - Reports 10-Mar-23 13:20 )
Ajanta Pharma
( Results - Analysis 31-Oct-23 23:40 )
Ajanta Pharma AGM scheduled
( Corporate News - 15-Jun-24 10:25 )
Ajanta Pharma
( Results - Analysis 01-Feb-23 17:14 )
Ajanta Pharma board OKs Rs 315-cr share buyback
( Hot Pursuit - 10-Mar-23 11:54 )
Board of Ajanta Pharma approves buyback of shares for Rs 315 cr
( Corporate News - 10-Mar-23 11:33 )
Ajanta Pharma consolidated net profit declines 7.20% in the September 2019 quarter
( Results - Announcements 06-Nov-19 15:37 )
Ajanta Pharma allots 7500 equity shares
( Corporate News - 14-Sep-18 12:43 )
Board of Ajanta Pharma recommends Second Interim Dividend
( Corporate News - 31-Jan-24 17:15 )
Decent Q1 numbers vitalize Ajanta Pharma
( Hot Pursuit - 01-Aug-19 12:41 )
Other Stories
Aarti Industries allots 13,178 equity shares under ESOP
04-Jul-24 20:31
FSN E-Commerce Ventures announces incorporation of subsidiary in Qatar
04-Jul-24 20:30
Board of KDDL to consider proposal for buyback of shares
04-Jul-24 20:28
Aptech allots 821 equity shares under ESOP
04-Jul-24 20:27
InterGlobe Aviation allots 1.88 lakh equity shares under ESOS
04-Jul-24 20:25
H.G. Infra Engineering announces incorporation of step-down subsidiary
04-Jul-24 20:21
Raymond demerges its real estate biz into Raymond Realty
04-Jul-24 20:15
UTI AMD allots 13,512 equity shares under ESOS
04-Jul-24 20:12
DCB Bank announces change in senior management
04-Jul-24 20:08
Network 18 Media & Investments appoints director
04-Jul-24 20:02
Back
Top
